{"id":"https://openalex.org/W4396989938","doi":"https://doi.org/10.1681/asn.20223311s1673a","title":"Empagliflozin Use and the Risk of Nephrolithiasis in Patients With Type 2 Diabetes","display_name":"Empagliflozin Use and the Risk of Nephrolithiasis in Patients With Type 2 Diabetes","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4396989938","doi":"https://doi.org/10.1681/asn.20223311s1673a"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20223311s1673a","doi":"https://doi.org/10.1681/asn.20223311s1673a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1673a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085331349","display_name":"Julie M. Paik","orcid":"https://orcid.org/0000-0002-1315-5445","observed_orcids":["https://orcid.org/0000-0002-1315-5445"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie M. Paik","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074777366","display_name":"Helen Tesfaye","orcid":"https://orcid.org/0000-0002-6264-2813","observed_orcids":["https://orcid.org/0000-0002-6264-2813"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Tesfaye","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047891240","display_name":"Heidi Zakoul","orcid":"https://orcid.org/0009-0008-3022-9013","observed_orcids":["https://orcid.org/0009-0008-3022-9013"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Zakoul","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062333721","display_name":"Niklas Schmedt","orcid":"https://orcid.org/0000-0002-6226-9537","observed_orcids":["https://orcid.org/0000-0002-6226-9537"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Niklas Schmedt","raw_affiliation_strings":["Boehringer Ingelheim International GmbH, Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim International GmbH, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026499631","display_name":"Lisette Koeneman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lisette Koeneman","raw_affiliation_strings":["Lilly Deutschland GmbH, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Deutschland GmbH, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081810419","display_name":"LEO J. SEMAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo Seman","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051186379","display_name":"Gary C. Curhan","orcid":"https://orcid.org/0000-0001-7386-6305","observed_orcids":["https://orcid.org/0000-0001-7386-6305"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary C. Curhan","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076997901","display_name":"Deborah J. Wexler","orcid":"https://orcid.org/0000-0001-6979-402X","observed_orcids":["https://orcid.org/0000-0001-6979-402X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah J. Wexler","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044474781","display_name":"Elisabetta Patorno","orcid":"https://orcid.org/0000-0002-8809-9898","observed_orcids":["https://orcid.org/0000-0002-8809-9898"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabetta Patorno","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"11S","first_page":"673","last_page":"673"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7886000275611877,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7886000275611877,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10606","display_name":"Kidney Stones and Urolithiasis Treatments","score":0.17829999327659607,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/kidney-stones","display_name":"kidney stones","score":0.9959999918937683},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9649999737739563},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4860000014305115},{"id":"https://openalex.org/keywords/urinary-flow","display_name":"urine flow","score":0.5720000267028809},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9567887187004089},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7354627847671509},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7068722248077393},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.593376874923706},{"id":"https://openalex.org/C2777693530","wikidata":"https://www.wikidata.org/wiki/Q6594689","display_name":"Benzhydryl compounds","level":4,"score":0.5822672247886658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4575343430042267},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3911812901496887},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27795371413230896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06186336278915405},{"id":"https://openalex.org/C2779684741","wikidata":"https://www.wikidata.org/wiki/Q271980","display_name":"Bisphenol A","level":3,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C166595027","wikidata":"https://www.wikidata.org/wiki/Q143983","display_name":"Epoxy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20223311s1673a","doi":"https://doi.org/10.1681/asn.20223311s1673a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1673a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308132695","https://openalex.org/W4317564550","https://openalex.org/W4282002954","https://openalex.org/W4391309738","https://openalex.org/W4405314599","https://openalex.org/W4411436720","https://openalex.org/W4408170409","https://openalex.org/W4408070463","https://openalex.org/W4381377379","https://openalex.org/W4399481862"],"abstract_inverted_index":{"Background:":[0],"Type":[1],"2":[2,53],"diabetes":[3],"(T2D)":[4],"is":[5,15],"associated":[6,199],"with":[7,70,148,200,214],"an":[8],"increased":[9],"risk":[10,25,42,138,203],"of":[11,26,43,64,132,139,180,204],"kidney":[12],"stones.":[13],"Empagliflozin":[14],"a":[16,75,85,129,185,201],"sodium-glucose":[17],"cotransporter-2":[18],"inhibitor":[19,77],"(SGLT2i)":[20],"which":[21],"might":[22],"lower":[23,142],"the":[24,35,41,100,124,137,144,149,163,181],"nephrolithiasis,":[27,205],"potentially":[28],"by":[29,96],"increasing":[30],"urinary":[31],"flow.":[32],"We":[33,105],"investigated":[34],"association":[36],"between":[37],"empagliflozin":[38,73,83,145,196],"use":[39,197,211],"and":[40,57,79,113,162,209],"nephrolithiasis":[44,94,140],"in":[45,99,123,143,212],"routine":[46,194],"practice.":[47],"Methods:":[48],"Using":[49],"claims":[50],"data":[51],"from":[52],"private":[54],"health":[55],"plans":[56],"Medicare":[58],"(2013-2019),":[59],"we":[60],"identified":[61],"102,275":[62],"pairs":[63,81],"1:1":[65],"propensity":[66],"score":[67],"(PS)-matched":[68],"adults":[69],"T2D":[71],"initiating":[72,82],"or":[74,84,102],"DPP4":[76],"(DPP4i),":[78],"115,489":[80],"GLP1":[86],"receptor":[87],"agonist":[88],"(GLP1RA).":[89],"Our":[90],"primary":[91],"outcome":[92,182],"was":[93,141,198],"diagnosed":[95],"ICD":[97],"codes":[98],"inpatient":[101],"outpatient":[103],"setting.":[104],"estimated":[106],"hazard":[107],"ratios":[108],"(HRs),":[109],"rate":[110],"differences":[111],"(RD)":[112],"95%":[114],"confidence":[115],"intervals":[116],"(CI),":[117],"adjusting":[118],"for":[119],"148":[120],"baseline":[121],"covariates":[122],"PS":[125],"model.":[126],"Results:":[127],"Over":[128],"mean":[130],"follow-up":[131],"\u02dc8":[133],"months":[134],"on":[135,184],"treatment,":[136],"group":[146,151,165],"compared":[147,206],"DPP4i":[150,208],"(HR":[152,166],"0.72":[153],"[95%CI":[154,159,168,173],"0.67-0.78];":[155],"RD/1,000":[156,170],"person-years":[157,171],"-6.2":[158],"-7.6,":[160],"-4.8])":[161],"GLP1RA":[164,210],"0.73":[167],"0.68-0.79];":[169],"-6.0":[172],"-7.4,":[174],"-4.6])":[175],"(see":[176],"Table).":[177],"Secondary":[178],"definitions":[179],"based":[183],"hospital":[186],"discharge":[187],"diagnosis":[188],"produced":[189],"consistent":[190],"results.":[191],"Conclusions:":[192],"In":[193],"care,":[195],"reduced":[202],"to":[207],"patients":[213],"T2D.":[215],"Funding:":[216],"Commercial":[217],"Support":[218],"-":[219],"Boehringer":[220],"Ingelheim":[221]},"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-05-18T00:00:00"}